Lawson Kroeker Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.21M Sell
174,686
-16,172
-8% -$423K 1.17% 30
2026
Q1
$5.36M Sell
190,858
-1,913
-1% -$50.9K 1.56% 24
2025
Q4
$4.8M Sell
192,771
-8,895
-4% -$224K 1.43% 26
2025
Q3
$5.14M Sell
201,666
-5,985
-3% -$148K 0.94% 35
2025
Q2
$5.03M Sell
207,651
-2,275
-1% -$53.1K 0.94% 35
2025
Q1
$5.32M Sell
209,926
-850
-0.4% -$22.2K 0.98% 34
2024
Q4
$5.59M Sell
210,776
-7,535
-3% -$204K 1.05% 33
2024
Q3
$6.32M Sell
218,311
-4,350
-2% -$127K 1.15% 29
2024
Q2
$6.23M Sell
222,661
-80
-0% -$2.2K 1.2% 30
2024
Q1
$6.33M Sell
222,741
-7,835
-3% -$217K 1.2% 30
2023
Q4
$6.64M Sell
230,576
-10,216
-4% -$309K 1.36% 29
2023
Q3
$7.99M Buy
240,792
+1,275
+0.5% +$45.1K 1.76% 21
2023
Q2
$8.79M Buy
239,517
+1,725
+0.7% +$67.1K 2.11% 17
2023
Q1
$9.7M Sell
237,792
-7,850
-3% -$339K 2.18% 16
2022
Q4
$12.6M Sell
245,642
-275
-0.1% -$13.2K 4.25% 4
2022
Q3
$10.8M Sell
245,917
-100
-0% -$4.86K 3.78% 6
2022
Q2
$12.9M Sell
246,017
-23,450
-9% -$1.19M 4.35% 4
2022
Q1
$13.9M Sell
269,467
-500
-0.2% -$25.9K 4.39% 5
2021
Q4
$15.9M Sell
269,967
-752
-0.3% -$37.3K 4.95% 4
2021
Q3
$11.6M Sell
270,719
-6,985
-3% -$309K 3.86% 7
2021
Q2
$10.9M Sell
277,704
-2,440
-0.9% -$94.9K 3.44% 8
2021
Q1
$10.2M Sell
280,144
-545
-0.2% -$19.4K 3.47% 8
2020
Q4
$10.3M Sell
280,689
-16,390
-6% -$601K 3.87% 6
2020
Q3
$10.3M Buy
297,079
+10,945
+4% +$384K 4.61% 5
2020
Q2
$8.88M Sell
286,134
-316
-0.1% -$10.7K 4.19% 7
2020
Q1
$8.87M Buy
286,450
+432
+0.2% +$14.7K 4.93% 4
2019
Q4
$10.6M Sell
286,018
-4,484
-2% -$160K 3.93% 8
2019
Q3
$9.9M Sell
290,502
-23,347
-7% -$849K 3.77% 9
2019
Q2
$12.9M Sell
313,849
-1,159
-0.4% -$46K 4.33% 5
2019
Q1
$12.7M Sell
315,008
-5,644
-2% -$226K 4.53% 4
2018
Q4
$13.3M Sell
320,652
-3,507
-1% -$146K 5.21% 2
2018
Q3
$13.6M Sell
324,159
-674
-0.2% -$25.9K 4.4% 3
2018
Q2
$11.2M Sell
324,833
-1,165
-0.4% -$39.8K 3.98% 5
2018
Q1
$11M Sell
325,998
-643
-0.2% -$22.1K 3.59% 9
2017
Q4
$11.2M Sell
326,641
-25,745
-7% -$878K 3.61% 9
2017
Q3
$11.9M Sell
352,386
-1,354
-0.4% -$43.5K 3.76% 6
2017
Q2
$11.3M Sell
353,740
-3,686
-1% -$116K 3.78% 7
2017
Q1
$11.6M Sell
357,426
-1,660
-0.5% -$52.3K 3.93% 5
2016
Q4
$11.1M Sell
359,086
-53,227
-13% -$1.62M 3.8% 5
2016
Q3
$13.3M Sell
412,313
-185
-0% -$6.19K 4.28% 3
2016
Q2
$13.8M Sell
412,498
-2,266
-0.5% -$72.3K 4.57% 2
2016
Q1
$11.7M Sell
414,764
-2,672
-0.6% -$76.3K 4.01% 6
2015
Q4
$12.8M Sell
417,436
-16,742
-4% -$527K 4.42% 5
2015
Q3
$12.9M Sell
434,178
-5,892
-1% -$189K 4.34% 5
2015
Q2
$14M Sell
440,070
-1,133
-0.3% -$36.9K 4.15% 4
2015
Q1
$14.6M Sell
441,203
-1,371
-0.3% -$43.6K 4.24% 4
2014
Q4
$13.1M Sell
442,574
-26
-0% -$746 4.11% 3
2014
Q3
$12.4M Sell
442,600
-1,112
-0.3% -$31.2K 3.71% 7
2014
Q2
$12.5M Buy
443,712
+3,786
+0.9% +$108K 3.64% 6
2014
Q1
$13.4M Buy
439,926
+2,846
+0.7% +$84.9K 4.19% 4
2013
Q4
$12.7M Sell
437,080
-4,058
-0.9% -$118K 4.03% 4
2013
Q3
$12M Sell
441,138
-2,793
-0.6% -$76K 4% 3
2013
Q2
$11.8M Buy
+443,931
New +$12.3M 4.12% 2

Other funds holding PFE

Lawson Kroeker Investment Management's PFE Position: Q2 2026 in Review

Lawson Kroeker Investment Management reduced its Pfizer (PFE) stake by 8.5% in Q2 2026, selling an estimated $423K and leaving 174,686 shares worth $4.21M. The position accounts for 1.17% of the portfolio, ranked #30.

Lawson Kroeker Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.9M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Lawson Kroeker Investment Management held 174,686 shares of Pfizer worth $4.21M as of Q2 2026.
  • Lawson Kroeker Investment Management sold 16,172 Pfizer shares in Q2 2026, an estimated $423K.
  • Pfizer made up 1.17% of Lawson Kroeker Investment Management's portfolio in Q2 2026, its #30 holding.
  • Lawson Kroeker Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Lawson Kroeker Investment Management's Pfizer position peaked at $15.9M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Lawson Kroeker Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.